${alertText}
Want unlimited access? Try Pro free for 7 days.
Learn more
Image 1
Image 2
IGMS
Imvotamab (IGM-2323) (CD20 x CD3)
Rheumatoid arthritis (RA)
Phase 1b
TBA
XBIT
Natrunix
Rheumatoid Arthritis (RA)
Phase 2
RIGL
R289
Lower-risk myelodysplastic syndrome (LR-MDS)
YE 2024